Technology News and Research

RSS

John Muir Health opens The Hofmann Family Patient Care Tower

Today, John Muir Health opened the doors of The Hofmann Family Patient Care Tower at John Muir Medical Center, Concord, which includes 120 new private rooms (61 open with 59 shelled for future use), a new Cardiovascular Institute and a new Emergency Department. The 172,000 square foot facility, which took three years and $212 million to complete, also features state-of-the-art technology and a patient-focused, healing environment.

17 Nov 2010

HCI unveils next-generation technology platform for fraud, waste, and abuse prevention and detection

HealthCare Insight (HCI) today unveiled Nucleus™, a next-generation technology platform for fraud, waste, and abuse prevention and detection, at the Annual Training Conference & Anti-Fraud Expo of the National Healthcare Anti-Fraud Association (NHCAA). The Nucleus application features advanced analytics, comprehensive risk scoring, and a customizable interface to help insurers stop fraud before medical claims are paid.

17 Nov 2010

Eisai enters strategic drug discovery collaboration with FORMA Therapeutics

Eisai Inc., the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., and FORMA Therapeutics announced today that the two companies have signed a strategic drug discovery collaboration.

17 Nov 2010

Enzon presents data on three investigational mRNA antagonists at EORTC-NCI-AACR Symposium

Enzon Pharmaceuticals, Inc. today presented data from preclinical studies of three investigational messenger RNA (mRNA) antagonists. These antagonists are based on the locked nucleic acid (LNA) technology platform targets licensed from Santaris Pharma A/S.

17 Nov 2010

St. Jude Medical and ZONARE enter partnership in ultrasound imaging

St. Jude Medical, Inc., a global medical device company and ZONARE Medical Systems, a leading provider of premium ultrasound systems, today announced they have entered into a development and marketing agreement. Under this agreement, the companies will combine the St. Jude Medical intracardiac echocardiography (ICE) catheter and the ZONARE z.one Convertible Ultrasound system technology, and co-market an ultrasound system for intracardiac (inside the heart) imaging.

17 Nov 2010

Chimerix’s lipid-conjugated drugs reduces nephrotoxicity: Study

Scientists from Chimerix, Inc. today presented in vitro data demonstrating that the company's lipid-conjugated drugs, CMX001 and CMX157, are not substrates for the human Organic Anion Transporters (hOATs) and thus have significantly reduced potential to cause nephrotoxicity via this mechanism.

17 Nov 2010

NDSsi selected by PENTAX as preferred partner for medical visualization solutions

The US-market leader in surgical displays, NDS Surgical Imaging (NDSsi) has been selected by PENTAX Europe GmbH as the preferred partner and supplier of medical visualization solutions. The agreement signals a Europe-wide expansion in the relationship between two companies renowned for technology innovation.

17 Nov 2010

MedAssets acquires The Broadlane Group

MedAssets, Inc. today announced that it has completed its acquisition of The Broadlane Group. The combination of MedAssets and Broadlane creates the industry's leading, end-to-end financial improvement partner that has saved billions for its healthcare provider customers, including more than $2.8 billion in documented and guaranteed supply chain savings.

17 Nov 2010

Swissmedic approves use of plasma components treated with Cerus' INTERCEPT Blood System

Cerus Corporation announced today that the Swiss regulatory body, Swissmedic, has approved the use of plasma components treated with Cerus' INTERCEPT Blood System.

17 Nov 2010

Officials look to 2 states for advice on setting up exchanges; other health overhaul news

Two states Massachusetts and Utah are forerunners in establishing health insurance exchanges, a key part of the health overhaul, and are likely to serve as models for other states, Politico reports.

17 Nov 2010

UMass, PolyMedix receive Phase 2 STTR contract to conduct test on antimicrobial compounds

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, and the University of Massachusetts, Amherst (UMass), have received a Phase 2 Small Business Technology Transfer (STTR) contract in the amount of $750,000.

17 Nov 2010

Optivia, UCSF receive SBIR grant to develop transporter-based assay system

Optivia Biotechnology Inc., a leading provider of in vitro transporter assay services, today announced that the company and the University of California, San Francisco (UCSF), have received a Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to develop an innovative system for characterizing the role transporter proteins play in the disposition of drugs by the liver.

16 Nov 2010

Isis, Xenon enter collaboration to discover and develop antisense drugs for AI

Isis Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc. announced today a new collaboration to discover and develop antisense drugs as novel treatments for the common disease anemia of inflammation (AI).

16 Nov 2010

UCSF, Pfizer announce partnership to accelerate translation of biomedical research

UCSF and Pfizer, Inc. have formed a new partnership to accelerate the translation of biomedical research into effective new medications and therapies for patients.

16 Nov 2010

Medtronic acquires Osteotech

Moving to expand its Biologics product offerings, Medtronic, Inc., announced today it has completed the acquisition of Osteotech, following payment of $6.50 per share in cash for each share of Osteotech stock, with a total transaction value of approximately $123 million.

16 Nov 2010

Verastem closes $16 million Series A financing

Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat cancer by targeting cancer stem cells, today announced the closing of a $16 million Series A financing. Founding investor, Longwood Founders Fund, was joined by Bessemer Venture Partners, Cardinal Partners, and MPM Capital.

16 Nov 2010

Two-dimensional crystals from DNA origami tiles

DNA is more than just a carrier for our genetic information; DNA is also an outstanding nanoscale building material, as researchers led by Ned Seeman discovered thirty years ago. Seeman and his colleagues at the New York University (USA) have now used cross-shaped DNA tiles to produce an amazingly large grid structure that resembles woven fabric. As the researchers report in the journal Angewandte Chemie, these two-dimensional crystals attain dimensions of about 2×3 micrometers.

16 Nov 2010

Ingenuity collaborates with Sage to enhance predictive disease networks

Ingenuity Systems, a leading provider of information solutions for life science researchers, today announced a new collaboration with Sage Bionetworks, a non-profit leader in predictive disease network research.

16 Nov 2010

Medical Acoustics receives UB CAT/NYSTAR grant

Medical Acoustics LLC, a commercial-stage medical device company which employs acoustic technologies for diagnostic and therapeutic medical applications, today announced that it has been awarded a UB CAT/NYSTAR grant.

16 Nov 2010

New 3M Littmann auscultation device can transfer digitally captured patient sounds

With new technology announced today by 3M, a doctor in Minnesota can in real-time detect a murmur in the heart of a child in rural Arizona. Through the new 3M Littmann Scope-to-Scope Tele-Auscultation System, clinicians can transfer digitally captured patient sounds in real-time, from one stethoscope to another, no matter the distance.

16 Nov 2010

Technology News and Research

John Muir Health opens The Hofmann Family Patient Care Tower

HCI unveils next-generation technology platform for fraud, waste, and abuse prevention and detection

Eisai enters strategic drug discovery collaboration with FORMA Therapeutics

Enzon presents data on three investigational mRNA antagonists at EORTC-NCI-AACR Symposium

St. Jude Medical and ZONARE enter partnership in ultrasound imaging

Chimerix’s lipid-conjugated drugs reduces nephrotoxicity: Study

NDSsi selected by PENTAX as preferred partner for medical visualization solutions

MedAssets acquires The Broadlane Group

Swissmedic approves use of plasma components treated with Cerus' INTERCEPT Blood System

Officials look to 2 states for advice on setting up exchanges; other health overhaul news

UMass, PolyMedix receive Phase 2 STTR contract to conduct test on antimicrobial compounds

Optivia, UCSF receive SBIR grant to develop transporter-based assay system

Isis, Xenon enter collaboration to discover and develop antisense drugs for AI

UCSF, Pfizer announce partnership to accelerate translation of biomedical research

Medtronic acquires Osteotech

Verastem closes $16 million Series A financing

Two-dimensional crystals from DNA origami tiles

Ingenuity collaborates with Sage to enhance predictive disease networks

Medical Acoustics receives UB CAT/NYSTAR grant

New 3M Littmann auscultation device can transfer digitally captured patient sounds

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News